Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Nanogen, Novavax Shares Fail to Provide Payoffs

August 9th, 2006

Nanogen, Novavax Shares Fail to Provide Payoffs

Abstract:
Nanogen Inc., one of 25 companies in the Merrill Lynch Nanotech Index that manipulate particles smaller than 100 nanometers, has slumped since May. Novavax Inc., a vaccine developer in Malvern, Pennsylvania, has declined 44 percent. Reno, Nevada-based Altair Nanotechnologies Inc., which makes materials used in paints and fuel cells, has fallen 22 percent. BioSante Pharmaceuticals Inc., based in Lincolnshire, Illinois, has tumbled 51 percent, the biggest drop in the Merrill index.

Source:
bloomberg.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Nanogen

ML Nanotech Index

Novavax

Altair Nanotechnologies

BioSante Pharmaceuticals

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Chaotic electrons heed ‘limit’ in strange metals July 30th, 2021

Scientists release new AI-based tools to accelerate functional electronic materials discovery: The work could allow scientists to accelerate the discovery of materials showing a metal-insulator transition July 30th, 2021

UVA Engineering researchers join quest to demonstrate photonic systems-on-chip: Future applications include faster, more efficient data centers and next-generation millimeter-wave wireless communication July 30th, 2021

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project